Notably, the anti-tumor effect of Tfh cells was impaired by programmed cell death 1 ligand 1 (PD-L1)/programmed cell death 1 (PD-1) signaling, which could be reversed using neoadjuvant chemotherapy. This evidence concerns the gene PDCD1 and neoplasm.